this document is an adjunct to FDA's regulations and to the agency's guidance document entitled
In Vitro Diagnostic Devices: Guidance for the Preparation of 510(k) Submissions available
it does not supersede those publications, but is designed to provide additional guidance and clarification concerning information that we recommend be provided to FDA in premarket notification submissions for in vitro diagnostic devices. you may wish to consult with the division of chemistry and toxicology devices (DCTD) before beginning studies involving new technologies, analytes, or matrices.